NeOnc Technologies director Thomas Chen buys 47K shares
NEONC TECHNOLOGIES HOLDINGS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) director, officer and ten-percent owner Thomas C. Chen reported multiple purchases of Common Stock. On April 10 and 24, and August 14 and 17, 2026, entities associated with Chen bought an aggregate of 47,207 shares in open-market transactions at weighted average prices between about $3.85 and $5.17 per share. Certain holdings are indirect through a defined benefit plan, an IRA, HCWG LLC, NeuCen Biomedical Co. Ltd., T. R. Chen Third Family Limited Partnership, and the Tien Duan Chen Trust, with Chen disclaiming beneficial ownership beyond his pecuniary interest where noted.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1, F5, F4 | 2,472 | $4.0445 | $10K |
| Purchase | Common Stock F1, F3, F4 | 33,787 | $3.8477 | $130K |
| Purchase | Common Stock | 10,000 | $4.80 | $48K |
| Purchase | Common Stock F1, F2 | 948 | $5.1677 | $5K |
| holding | Common Stock F6 | -- | -- | -- |
| holding | Common Stock F7 | -- | -- | -- |
| holding | Common Stock F8 | -- | -- | -- |
| holding | Common Stock F9 | -- | -- | -- |
Footnotes (9)
- F1. The aggregate number of shares of Issuer's common stock (the "Shares") purchased by the Reporting Person on the same day at different prices.
- F2. Represents the weighted average purchase price. The Shares were purchased at prices ranging from $5.165 to $5.1722 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
- F3. Represents the weighted average purchase price. The Shares were purchased at prices ranging from $3.2299 to $4.0993 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
- F4. Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein.
- F5. Represents the weighted average purchase price. The Shares were purchased at prices ranging from $4.04 to $4.1699 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
- F6. Such shares represent only Reporting Person's percentage interest in HCWG LLC.
- F7. Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- F8. Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- F9. Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.
Key Figures
Key Terms
weighted average purchase price financial
beneficial ownership financial
pecuniary interest financial
Defined Benefit Plan financial
IRA financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did NTHI report for Thomas C. Chen in this Form 4/A?
What was the largest single-day NTHI purchase reported by Thomas C. Chen?
Were the reported NTHI trades made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.